Annual Results Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
4,565.34
3,890.13
3,688.39
3,070.25
3,315.87
2,751.97
2,178.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,565.34
3,890.13
3,688.39
3,070.25
3,315.87
2,751.97
2,178.37
Raw Material Cost
1,475.89
1,151.14
1,441.68
1,090.93
1,390.42
1,020.35
1,002.05
Purchase of Finished goods
688.08
554.84
187.87
316.11
296.08
146.94
187.15
(Increase) / Decrease In Stocks
-184.01
43.07
-2.67
95.28
-353.71
-44.81
-104.00
Employee Cost
862.76
737.05
732.02
646.91
550.15
442.56
329.44
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
919.79
821.65
899.30
941.13
798.10
671.03
521.42
Total Expenditure (Excl Depreciation)
3,762.52
3,307.75
3,258.21
3,090.36
2,681.04
2,236.07
1,936.06
Operating Profit (PBDIT) excl Other Income
802.82
582.38
430.18
-20.11
634.83
515.90
242.31
Other Income
58.72
39.70
90.33
131.99
51.43
53.11
40.84
Operating Profit (PBDIT)
861.54
622.08
520.51
111.88
686.26
569.01
283.15
Interest
248.85
280.22
261.14
176.74
150.07
155.72
79.29
Exceptional Items
3,252.77
-139.46
1.54
-243.83
43.35
-77.68
21.62
Gross Profit (PBDT)
677.35
152.81
242.34
-308.69
579.54
335.61
225.48
Depreciation
192.26
213.64
243.25
233.01
206.29
173.70
117.39
Profit Before Tax
485.08
-60.83
-0.92
-541.70
373.26
161.91
108.09
Tax
77.52
29.11
-55.30
-178.26
31.65
11.33
-26.86
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
407.57
-89.94
54.38
-363.44
341.61
150.58
134.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
3,188.11
49.59
18.57
0.00
13.94
-12.77
240.62
Net Profit
3,595.67
-40.35
72.95
-363.44
355.55
137.81
375.57
Share in Profit of Associates
1.84
-53.97
-285.28
-110.81
-97.82
-107.23
-45.70
Minority Interest
-4.06
23.70
9.70
14.04
10.71
5.80
-5.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,593.46
-70.62
-202.64
-460.21
268.44
36.38
324.61
Equity Capital
92.16
91.90
90.30
89.79
89.68
89.57
89.55
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
2,459.67
2,033.66
2,121.96
2,269.44
2,686.98
2,437.85
2,559.16
Earnings per share (EPS)
389.92
-3.37
-22.44
-51.25
29.93
4.06
36.25
Diluted Earnings per share
390.5
-3.4
-22.49
-51.28
29.92
4.06
36.24
Operating Profit Margin (Excl OI)
17.59%
14.97%
11.66%
-0.65%
19.15%
18.75%
11.12%
Gross Profit Margin
14.84%
3.93%
6.57%
-10.05%
17.48%
12.2%
10.35%
PAT Margin
8.97%
-3.7%
-6.26%
-15.45%
7.35%
1.58%
4.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 17.36% vs 5.47% in Mar 2024
Consolidate Net Profit
YoY Growth in year ended Mar 2025 is 5,188.45% vs 65.15% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 37.85% vs 35.38% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -11.19% vs 7.31% in Mar 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2025 has improved from Mar 2024
Compare Annual Results Of Strides Pharma With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
4,565.34
2,622.85
1,942.49
74.06%
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,565.34
2,622.85
1,942.49
74.06%
Raw Material Cost
1,475.89
753.02
722.87
96.00%
Purchase of Finished goods
688.08
574.48
113.60
19.77%
(Increase) / Decrease In Stocks
-184.01
-183.76
-0.25
-0.14%
Employee Cost
862.76
350.30
512.46
146.29%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
919.79
596.12
323.67
54.30%
Total Expenditure (Excl Depreciation)
3,762.52
2,090.16
1,672.36
80.01%
Operating Profit (PBDIT) excl Other Income
802.82
532.69
270.13
50.71%
Other Income
58.72
66.33
-7.61
-11.47%
Operating Profit (PBDIT)
861.54
599.02
262.52
43.82%
Interest
248.85
11.66
237.19
2,034.22%
Exceptional Items
3,252.77
0.00
3,252.77
Gross Profit (PBDT)
677.35
587.36
89.99
15.32%
Depreciation
192.26
83.39
108.87
130.56%
Profit Before Tax
485.08
503.97
-18.89
-3.75%
Tax
77.52
121.35
-43.83
-36.12%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
407.57
382.62
24.95
6.52%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
3,188.11
0.00
3,188.11
Net Profit
3,595.67
382.62
3,213.05
839.75%
Share in Profit of Associates
1.84
0.00
1.84
Minority Interest
-4.06
-2.04
-2.02
-99.02%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,593.46
380.58
3,212.88
844.21%
Equity Capital
92.16
45.32
46.84
103.35%
Face Value
10.00
1.00
0.00
Reserves
2,459.67
2,421.60
38.07
1.57%
Earnings per share (EPS)
389.92
8.40
381.52
4,541.90%
Diluted Earnings per share
390.50
8.40
382.10
4,548.81%
Operating Profit Margin (Excl OI)
17.59%
20.31%
0.00
-2.72%
Gross Profit Margin
14.84%
22.39%
0.00
-7.55%
PAT Margin
8.97%
14.59%
0.00
-5.62%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 4,565.34 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.36% vs 5.47% in Mar 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 3,593.46 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 5,188.45% vs 65.15% in Mar 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 802.82 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 37.85% vs 35.38% in Mar 2024
Annual - Interest
Interest 248.85 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -11.19% vs 7.31% in Mar 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 17.59%
in Mar 2025Figures in %
YoY Growth in year ended Mar 2025 has improved from Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
